These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Pertussis vaccination: use of acellular pertussis vaccines among infants and young children. Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep; 1997 Mar; 46(RR-7):1-25. PubMed ID: 9091780 [TBL] [Abstract][Full Text] [Related]
3. Sustained efficacy during the first 6 years of life of 3-component acellular pertussis vaccines administered in infancy: the Italian experience. Salmaso S; Mastrantonio P; Tozzi AE; Stefanelli P; Anemona A; Ciofi degli Atti ML; Giammanco A; Pediatrics; 2001 Nov; 108(5):E81. PubMed ID: 11694665 [TBL] [Abstract][Full Text] [Related]
5. Comparison of a fifth dose of a five-component acellular or a whole cell pertussis vaccine in children four to six years of age. Halperin SA; Scheifele D; Barreto L; Pim C; Guasparini R; Medd L; Meekison W; Eastwood BJ Pediatr Infect Dis J; 1999 Sep; 18(9):772-9. PubMed ID: 10493336 [TBL] [Abstract][Full Text] [Related]
6. Effect of priming with diphtheria and tetanus toxoids combined with whole-cell pertussis vaccine or with acellular pertussis vaccine on the safety and immunogenicity of a booster dose of an acellular pertussis vaccine containing a genetically inactivated pertussis toxin in fifteen- to twenty-one-month-old children. Italian Multicenter Group for the Study of Recombinant Acellular Pertussis Vaccine. Podda A; Bona G; Canciani G; Pistilli AM; Contu B; Furlan R; Meloni T; Stramare D; Titone L; Rappuoli R J Pediatr; 1995 Aug; 127(2):238-43. PubMed ID: 7636648 [TBL] [Abstract][Full Text] [Related]
7. Letter to the editor: Is the acellular pertussis vaccine driving the increase in severe whooping cough cases in children? Prevost B; Nathan N; Corvol H Euro Surveill; 2024 Sep; 29(37):. PubMed ID: 39268650 [No Abstract] [Full Text] [Related]
8. A controlled trial of two acellular vaccines and one whole-cell vaccine against pertussis. Progetto Pertosse Working Group. Greco D; Salmaso S; Mastrantonio P; Giuliano M; Tozzi AE; Anemona A; Ciofi degli Atti ML; Giammanco A; Panei P; Blackwelder WC; Klein DL; Wassilak SG N Engl J Med; 1996 Feb; 334(6):341-8. PubMed ID: 8538704 [TBL] [Abstract][Full Text] [Related]
9. A safety and immunogenicity comparison of 12 acellular pertussis vaccines and one whole-cell pertussis vaccine given as a fourth dose in 15- to 20-month-old children. Pichichero ME; Deloria MA; Rennels MB; Anderson EL; Edwards KM; Decker MD; Englund JA; Steinhoff MC; Deforest A; Meade BD Pediatrics; 1997 Nov; 100(5):772-88. PubMed ID: 9346976 [TBL] [Abstract][Full Text] [Related]
10. A controlled trial of a two-component acellular, a five-component acellular, and a whole-cell pertussis vaccine. Gustafsson L; Hallander HO; Olin P; Reizenstein E; Storsaeter J N Engl J Med; 1996 Feb; 334(6):349-55. PubMed ID: 8538705 [TBL] [Abstract][Full Text] [Related]
11. The 112-Year Odyssey of Pertussis and Pertussis Vaccines-Mistakes Made and Implications for the Future. Cherry JD J Pediatric Infect Dis Soc; 2019 Sep; 8(4):334-341. PubMed ID: 30793754 [TBL] [Abstract][Full Text] [Related]
13. Impact of infant and preschool pertussis vaccinations on memory B-cell responses in children at 4 years of age. Hendrikx LH; de Rond LG; Oztürk K; Veenhoven RH; Sanders EA; Berbers GA; Buisman AM Vaccine; 2011 Aug; 29(34):5725-30. PubMed ID: 21669247 [TBL] [Abstract][Full Text] [Related]
14. Reduced-antigen, combined diphtheria, tetanus and acellular pertussis vaccine, adsorbed (Boostrix®): a review of its properties and use as a single-dose booster immunization. McCormack PL Drugs; 2012 Sep; 72(13):1765-91. PubMed ID: 22931522 [TBL] [Abstract][Full Text] [Related]
15. Acellular pertussis vaccine as a booster dose for seventeen- to nineteen-month-old children immunized with either whole cell or acellular pertussis vaccine at two, four and six months of age. Halperin SA; Mills E; Barreto L; Pim C; Eastwood BJ Pediatr Infect Dis J; 1995 Sep; 14(9):792-7. PubMed ID: 8559630 [TBL] [Abstract][Full Text] [Related]
16. Diphtheria-tetanus-acellular pertussis vaccine adsorbed (Triacelluvax; DTaP3-CB): a review of its use in the prevention of Bordetella pertussis infection. Matheson AJ; Goa KL Paediatr Drugs; 2000; 2(2):139-59. PubMed ID: 10937466 [TBL] [Abstract][Full Text] [Related]
17. Acellular vaccines containing reduced quantities of pertussis antigens as a booster in adolescents. Tran Minh NN; He Q; Ramalho A; Kaufhold A; Viljanen MK; Arvilommi H; Mertsola J Pediatrics; 1999 Dec; 104(6):e70. PubMed ID: 10586004 [TBL] [Abstract][Full Text] [Related]
19. Alternative diphtheria, tetanus and whooping cough immunization schedule to evoke a Th2 tetanus and a Th1 pertussis immune response. Lavigne MV; Castro M; Andino J; Manghi M Microbes Infect; 2004 Apr; 6(5):481-4. PubMed ID: 15109963 [TBL] [Abstract][Full Text] [Related]